We have examined the regulation of GLUT4 phosphorylation in adipocytes isolated from diabetic rats. Despite progressive (40-70%) reductions in GLUT4 protein contents on the 2nd, 7th, and 14th day of diabetes, the phosphorylation of GLUT4 was increased two-to fourfold. These alterations were accompanied by concomitant reductions (40-66%) in the insulin-stimulated 2-deoxyglucose transport. Insulin treatment of diabetic animals for 5 d restored glucose transport activity, GLUT4 protein, and GLUT4 phosphorylation to control levels whereas vanadate and phlorizin were ineffective. In control adipocytes, insulin promoted GLUT4 translocation from the low density microsomal (LDM) pool to the plasma membranes (PM) and decreased the state of GLUT4 phosphorylation. In adipocytes isolated from the diabetic rats, insulin failed to stimulate GLUT4 translocation and to decrease GLUT4 phosphorylation. To explore the mechanism of the diabetes-induced increases in the GLUT4 phosphorylation, we investigated phosphoserine phosphatase (PSPase) activities using 32P-labeled GLUT4 and phosphorylase "a" as substrates. Diabetes resulted in 50-60% increase in the particulate PSPase activity and concomitant reductions in cytosolic PSPase activities. Although reduced cytosolic PSPase activity correlated with an inadequate dephosphorylation of LDM GLUT4, the existence of highly phosphorylated PM GLUT4 in the presence of increased particulate PSPase activity required additional explanation. To address this problem, we used PM GLUT4 from diabetic rats as a substrate of particulate PSPase. Highly active diabetic particulate PSPase, which dephosphorylated control GLUT4 and phosphorylase a, failed to dephosphorylate PM GLUT4 from diabetic rats. These data suggest that PM GLUT4 from diabetic rats is unable to interact with PSPase or that its phosphorylation sites are not accessible to PSPase action. In summary, an induction of diabetes with streptozotocin resulted in significant increases in GLUT4 phosphorylation.
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In contrast to normal cells, insulin failed to promote GLUT4 recruitment to the plasma membranes and its dephosphorylation in diabetic adipocytes. At the same time, diabetes appears to induce redistribution of PSPases, resulting in lower cytosolic activity and higher particulate activity. It also appears that the existence of highly phosphorylated GLUT4 in the plasma membranes of diabetic adipocytes resulted from its inability to 
Introduction
In adipocytes and skeletal muscle cells, insulin stimulates glucose transport by promoting translocation of glucose transporters (GLUT-4) from the intracellular pool to the plasma membranes and by increasing their intrinsic activity (1) (2) (3) . In streptozotocin-induced diabetes in rats as well as noninsulin-dependent diabetes in humans, there appears to be a reduction in the size of the intracellular pool of transporters (4) (5) (6) (7) (8) . Moreover, there is a clear diminution in the ability of insulin to recruit to the plasma membranes and to enhance their intrinsic activity (9, 10) . The mechanism of this diabetes-induced insulin resistance (which is reversible with insulin therapy) remains incompletely understood.
One possibility is that alterations in the phosphorylation of GLUT-4 may impair its functioning. Although insulin does not appear to phosphorylate GLUT-4 to promote glucose transport (1 1, 12), other agents that increase its phosphorylation (i.e., isoproterenol, okadaic acid, high levels of cytosolic Ca2+) decrease insulin-stimulated glucose uptake ( 13, 14) . We hypothesized that excessive phosphorylation ofGLUT-4 may interfere with its responsiveness to stimulation by insulin. Since insulin activates several intracellular enzymes (e.g., glycogen synthase, pyruvate dehydrogenase) by promoting their dephosphorylation, it is possible that insulin exerts a similar effect on GLUT-4. Thus, in the case ofinsulin deficiency, (12, 13) . The 32P-labeled cells from control and diabetic rats were subsequently divided into two equal groups, one ofwhich was incubated with insulin ( 100 nM) for an additional 30 min. At the end ofthe incubation, the cells were centrifuged at 800 g for 15 s and the medium was aspirated. The cells were rinsed at 37°C in HES buffer containing phosphatase and protease inhibitors ( 13 ) . The cells were immediately homogenized at 0°C in HES buffer using aglass homogenizer and a teflon pestle (six strokes) at 1,500 rpm. HES buffer contained the following (mM): 10 Immunoprecipitation of 32P-labeled GLUT-4 and electrophoretic analyses. Glucose transporters were immunoprecipitated using the monoclonal antibody IF8 (12, 13) . SDS-solubilized PM, LDM, and cell homogenates ( 100 gl; 50-100 Mg of protein) were added to 900 Ml of HES buffer containing 1% Triton X-100, 100 mM NaCl, protease and phosphatase inhibitors. Samples were incubated for 30 min at 220C and centrifuged for 5 min at 13,000 g. Supernatants were used for immunoprecipitation with IF8. The monoclonal antibody was first immobilized by incubation at 220C with goat anti-mouse IgG (binding capacity 0.4 mg IgG/ml packed beads) coupled to agarose beads (1 Mg of antimouse IgG/ 1 Mg of IF8) and was suspended in HES buffer containing 0.1% BSA. After 60 min of incubation with constant shaking, the beads were pelleted by centrifugation and washed three times with HES buffer containing 1% Triton X-100, 100 mM NaCl, protease and phosphatase inhibitors. Beads ( 100-200 Ml) were then added to solubilized samples and incubation was continued for 60 min at 220C with constant shaking. The samples were centrifuged at 13,000 g for l 0 s and the pelleted beads containing immune complexes were washed with HES containing 1% Triton X-100. SDS sample buffer (30 Ml) was added to elute glucose transporters. Samples were incubated for 10 min at 370C before electrophoresis was performed using 10% SDS-polyacrylamide resolving gels (19) . After electrophoresis, gels were dried and exposed to Kodak X-AR 5 film at -700C. 32P was quantitated by optical density scanning of autoradiograms and the results were compared with the cut and count technique. Low molecular weight standards from Bio-Rad Laboratories were always run with the sample to estimate the molecular weight of the glucose transporters.
Immunoblotting was performed to estimate the relative amounts of transporters in control and diabetic preparations and in different subcellular fractions. Proteins were electrophoretically transferred from SDS gels to nitrocellulose sheets or immunolite membranes supplied by Bio-Rad Laboratories according to the manufacturer's instructions. To identify the GLUT-4 transporter, the membranes were incubated with the polyclonal antibody R820 (12, 13) . Antibody binding was detected by chemiluminescence (Bio-Rad Laboratories).
Assay of PSPase activity. PSPase activity present in particulate (PF) and cytosolic fractions (CF) ofcontrol and diabetic rat adipocytes was measured according to the method of Shenolikar and Ingebritsen (20) , using purified 32P-labeled phosphorylase a and 32P-labeled GLUT-4 as substrates. PF and CF were prepared from control and diabetic adipocytes according to the method of King and Sale (21 ) . PF and CF (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) Mg protein/assay) were preincubated for 2 min at 300C.
The reaction was started by the addition ofa reaction mixture containing (final concentration) 1 mg/ml of [32P]phosphorylase a, 40 mM Tris-Hcl (pH 7.0), 1 mM EDTA, 20 mM ,B-mercaptoethanol in a final volume of 100 Ml. At the end of 10 min, the assay was terminated by the addition of 100 Ml of20% TCA and 10 Ml of 1% BSA as a carrier protein.
Samples were centrifuged at 12,000 g for 5 min and aliquots of the supernatant were added to 4 ml of scintillation fluid and counted.
When 32P-labeled GLUT4 was used as a substrate, purified 32P-labeled LDM fractions containing 25,000-30,000 cpm were incubated with PF or CF ( 12-24 Mg protein) in a final volume of 100 Ml. The reaction mixture contained 40 mM Tris-Hcl, pH 7.0, 1 mM EDTA, 20 mM 13-mercaptoethanol, and 10 Mg/ml aprotinin. After 20 min of incubation at 300C, the reaction was stopped by the addition of HES buffer containing 1% SDS. The samples were diluted to 1 ml with HES buffer containing protease and phosphatase inhibitors and 1% Triton GLUT-4 Phosphorylation in Diabetes 1255 X-l00, and GLUT-4 was immunoprecipitated using IF8 antibody as described above. The immunoprecipitates were subjected to SDS-PAGE followed by autoradiography. 32P present in GLUT-4 was quantitated by densitometry. Percent dephosphorylation by PF or CF was calculated by subtracting the radioactivity remaining in GLUT-4 from the 32P present in GLUT-4 incubated with buffer alone. Western blotting of a duplicate gel was used to assess the GLUT-4 content. There was no reduction in GLUT-4 content during the incubation with PSPases. Therefore, the decrease in 32P content of GLUT-4 was due to dephosphorylation by PSPases rather than a reduction in the number of transporters immunoprecipitated.
[32P]phosphorylase a was prepared by incubating purified phosphorylase b with phosphorylase kinase, y[32P]ATP and Mg2' according to the method of Antoniw et al. (22) LDM or PM prepared from control rat adipocytes were phosphorylated in vitro with cAMP-dependent protein kinase according to the method of Stewart et al. (23) . Briefly, the reaction mixture in a final volume of 200 Ml, containing LDM ( 100 Mg protein/ 100 Ml), 6 mM MgCl2, 200 MuM ATP, 2 U catalytic subunit of protein kinase A, and 200 MuCi of y[32P]ATP was incubated for 1 h at 30°C. The reaction was terminated by the addition of 100 mM NaF followed by desalting using a small Sephadex G-25 column. The fraction containing 32P-labeled LDM was used for dephosphorylation assays.
Protein assay. The amount of proteins was determined by the method of Bradford (24) Effect ofdiabetes on insulin stimulated 2-deoxyglucose uptake.
Insulin-stimulated glucose transport was significantly reduced (P < 0.001) in diabetic rat adipocytes (Fig. 1) (Fig. 2, A and C) . The mobility of the phosphorylated band corresponded exactly with that ofthe glucose transporter detected by immunoblotting with a polyclonal antibody R820 (Fig. 2 B and D) . The summary ofthe densitometric analysis of several independent experiments is shown in Figs. 3 and 4 . The GLUT-4 protein content in diabetic adipocytes was significantly decreased compared with controls (Fig. 3) . Insulin treatment of diabetic rats for 5 d restored the GLUT-4 contents to control levels ( Fig. 3 ) whereas vanadate and phlorizin were without effect.
There was a two-to fourfold increase in phosphorylation status ofGLUT-4 (Fig. 4) after correction for variations in the proteins (i.e., GLUT-4 specific activity). To compare results from different experiments, the specific activity of the transporter in control cell homogenates was assigned a value of 1 and the rest ofthe data was calculated relative to control values. Insulin therapy restored GLUT-4 phosphorylation to normal whereas 5 d ofvanadate or phlorizin treatment were ineffective (Fig. 4) .
Effect of diabetes on the subcellular distribution ofphosphorylated glucose transporters. The bulk ofthe insulin-regulatable glucose transporters (GLUT-4) exists within the intracellular pool (2, 3) . Insulin stimulates translocation of GLUT-4 from the intracellular pool to the plasma membrane. We examined cellular distribution of GLUT-4 along with its state of phosphorylation in diabetic adipocytes (Fig. 5) . ed in translocation of GLUT-GLUT-4 from diabetic PM and LDM fractions was heavily PM (lanes 3 and 4) . In conphosphorylated in the basal state (Fig. 5 A, lanes S and 7) as inslocation of GLUT-4 in diawell as after treatment of adipocytes with insulin (lanes 6 >. 5 A demonstrates the degree and 8). in LDM and PM of control Quantitative densitometric analyses of the autoradiograms -8) adipocytes incubated with depicting GLUT-4 content and phosphorylation state are seen rast to control preparations, in Figs. 6 and 7. There was a significant reduction in the diabetic LDM GLUT-4 content compared with control LDM (Fig. 6 ). In contrast, diabetic PMs showed a significant increase (45%) in GLUT-4 content compared with control preparations. Although an exposure of adipocytes to insulin resulted in a five-to sixfold increase in GLUT-4 content in control PM, there was an impaired translocation of GLUT-4 in diabetes. Conceivably, impaired translocation of GLUT-4 in diabetes may be related to a high basal PM GLUT-4 content.
**
In control adipocytes, insulin significantly decreased phosphorylation ofGLUT-4 both in the PM and LDM fractions (P * * < 0.05, Fig. 7 ). To confirm these observations, we analyzed the effect of insulin on GLUT-4 content and phosphorylation in the total cell homogenate. 32P-labeled control adipocytes were used in these experiments. Western blotting revealed identical total cell lysate GLUT-4 in the insulin-treated and untreated firm that the 46-kD phosphorylated band was indeed GLUT-4. . (Fig. 8 A) . There was no signal when the preimmune 1.000* zC 0.800. Effect of diabetes on GLUT-4 dephosphorylation by PSPases. The state of phosphorylation of GLUT-4 reflects a balance between the activities of kinases that phosphorylate and the activities of phosphatases which dephosphorylate this protein. Studies by Lawrence et al. (13) have shown that GLUT-4 could be dephosphorylated by PP-l and PP-2A with equal affinities and okadaic acid, a potent phosphatase inhibitor, causes an increase in GLUT-4 phosphorylation.
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To investigate the mechanism of the increase in the phosphorylation of GLUT-4 in diabetes, we assessed phosphatase activity in diabetic adipocytes. The in vitro 32P-labeled LDM fraction from control adipocytes was used as substrate to assay PSPase activity present in the PF and CF of control and diabetic rat adipocytes. At the end of dephosphorylation reaction, the GLUT-4 was immunoprecipitated and analyzed by SDS-PAGE and autoradiography. The 32p content of GLUT-4 before and after treatment with PP-1 was quantitated by densitometric scanning. In a separate experiment, we observed that in normal adipocytes 52% of the phosphatase activity was associated with particulate fractions and 48% with the cytosolic fractions. Fig. 9 shows the representative autoradiogram ofthe immunoprecipitated GLUT-4 ( Fig. 9 A) and densitometric analysis ofthe 32P-GLUT-4 specific activity after dephosphorylation by PSPases (Fig. 9 B) . There was an apparent redistribution ofPSPases activity in diabetes. At 2 and 7 d ofdiabetes, we found an increase in particulate PSPase activity (lanes 2 vs. 3 and 6 vs. 7) and a corresponding decrease in cytosolic PSPase activity (lanes 4 vs. 5 and 9 vs. 10). Quantitative analysis demonstrated that particulate PSPases from diabetic rat adipocytes dephosphorylated GLUT-4 by 30±8% whereas PSPases from control preparations caused only 19±3.6% dephosphorylation.
Similar results were obtained when the GLUT-4 immunoprecipitated from control LDM was used as a substrate (not shown). Hence, diabetes resulted in a 50-65% increase in particulate PSPase activity. In contrast, cytosolic fractions from diabetic rats (either 2-or 7-d duration) showed a significant inhibition of PSPase activity (decreased dephosphorylation of . The loss of phosphatase activity in the cytosolic compartment was totally recovered in the particulate fraction, suggesting altered distribution of the PSPase between the two compartments (Fig. 9 B) . Insulin treatment restored the phosphatase activity to control levels in both compartments (Fig. 9  A, lanes 8 and 11, and Fig. 9 B) . Alterations in PSPase activity in diabetes were also confirmed using 32P-labeled phosphorylase a as a substrate of PSPase (Table I) . Since the activity ofthe diabetic PSPase appears to be increased when tested against control LDM GLUT-4 ( Fig. 9) , phosphorylase a (Table I) , and glycogen synthase ( 16) , it is likely that alterations in the substrate (diabetic PM GLUT-4) interfere with its normal dephosphorylation. To test this possibility, we used [32P]GLUT-4 prepared from control and diabetic PM as substrates of diabetic particulate PSPases (Fig. 10) . As expected, diabetic enzyme demonstrated much greater activity towards control PM GLUT-4 than control enzyme (P < 0.01 ). Neither control nor diabetic enzyme was able to dephosphorylate "diabetic" PM GLUT-4, suggesting that the glucose transporters present in the plasma membranes of diabetic adipocytes were unable to interact with the enzyme. It is ofinterest to note that although unable to dephosphorylate diabetic PM GLUT-4, the diabetic particulate PSPases were capable of de- phosphorylating the diabetic LDM GLUT-4 (data not shown), indicating that diabetic GLUT-4 becomes resistant to the PM PSPases after being translocated to the plasma membranes. Alternatively, the phosphorylated sites in diabetic PM GLUT-4 may not be accessible to PSPases. This observation was further confirmed in experiments with purified PP-l (Table II) . Purified skeletal muscle PP-l (a gift from Dr. Shenolikar, Duke
University, Durham, NC) dephosphorylated control PM GLUT-4 by 50-60% in 15 min. In contrast, when diabetic PM GLUT-4 was used as a substrate, the very same enzyme dephosphorylated it only by 18-20% (P < 0.05).
Discussion
Four salient observations were made in the course ofthis study. First, we found significantly increased phosphorylation of GLUT-4 in diabetes (Figs. 2, 4 , 5, and 8). This was observed in contrast to a profound decrease in the GLUT-4 content. Enhanced phosphorylation of GLUT-4 was evident both in the PM and LDM fractions. Second, insulin promoted dephosphorylation of GLUT-4 in control, but not in diabetic adipocytes. This modest, but significant dephosphorylation of GLUT-4 by insulin was seen in both subcellular compartments, LDM and PM (Figs. 5 and 7). Third, diabetes resulted in redistribution of PSPase activity, with a loss of such activity in the cytosol and an increase in the particulate fraction. This phenomenon was apparent when PSPase activity was tested with GLUT-4 or phosphorylase a as substrates (Fig. 9 , Table   I ). Finally, inability of highly active diabetic particulate
PSPases to dephosphorylate diabetic PM GLUT-4 could be attributed to alterations in diabetic GLUT-4 itself (Fig. 10 ). These observations taken together with the previous findings of substrate specificity for PSPases (27) ( 12, 13) . Diabetes is known to be accompanied by defective translocation of glucose transporters from the intracellular pool to the PM (4). The relationship ofthis defect to the state ofphosphorylation of GLUT-4 must be explored in the future. Phosphorylation of GLUT-4 has been suggested to alter its cellular distribution ( 13, 25 ) . Recent studies by Lawrence et al. ( 13) and others (25) suggested that the okadaic acid-induced inhibition oftranslocation ofGLUT-4 is due to increased reinternalization of GLUT-4 in a phosphorylated form. Studies by Corvera and Czech (32) and others (33, 34) showed that the insulin-like growth factor II (IGF II) receptor is translocated to the plasma membrane in response to insulin. Moreover, insulin causes a decrease in IGF II receptor phosphorylation in the plasma membranes. These authors showed that insulin-induced phosphorylation of IGF II receptors slowed their rate of internalization and proposed that insulin regulates the cellular location of IGF II receptors by affecting their phosphorylation state. A similar phenomenon may exist for GLUT-4.
Possible mechanisms of diabetes-induced elevations in GLUT-4 phosphorylation. The phosphorylation state of GLUT-4 represents a balance between the activities of kinases and phosphatases. An insulin-deficient state with predominance of cAMP-dependent activation can certainly increase GLUT-4 phosphorylation. On the other hand, an impaired dephosphorylation process may also maintain GLUT-4 in the phosphorylated state. GLUT-4 is phosphorylated on serine residues (26) , and both elevated levels of [Ca2+]i and cAMP have been previously shown to inhibit adipocyte PSPase activity (35) . Our recent observations indicate that the activity of the cytosolic PSPase was inhibited in diabetes, when it was tested with glycogen synthase as a substrate ( 16) . Therefore, to further investigate the mechanism of the observed increase in phosphorylation of GLUT-4 in diabetes, we assessed PSPase activity using (Fig. 10) revealed that diabetic PM glucose transporters failed to interact with the enzyme. In fact,
[32P]-GLUT-4 from diabetic plasma membranes was also poorly dephosphorylated by control PSPases and by the purified skeletal muscle PP-l. It is conceivable that phosphorylation of GLUT-4 in diabetes involves alternate sites which are unaccessible for the action of PSPase. In summary, we have shown that insulin-deficient diabetes results in increased GLUT-4 phosphorylation most likely via cAMP-mediated processes. Both enhanced kinase activity and diminished phosphatase activity may be responsible for shifting the balance in favor ofphosphorylation. Greater phosphorylation may render GLUT-4 less sensitive to acute regulation by insulin.
